New research highlights the fluctuating course of pediatric ADHD and the continued role of stimulant medications as first-line therapy.
Rebecca Chasnovitz, MD
Advertisement
Rebecca Chasnovitz, MD, is a general pediatrics and adolescent medicine specialist at the University of North Carolina at Chapel Hill.
Articles by Rebecca Chasnovitz, MD
Advertisement
Latest Updated Articles
Rebecca Chasnovitz, MD, highlights updates in pediatric ADHD medicationFebruary 24th 2026
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza
2
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
3
Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear
4
New sunscreen ingredient clears FDA for the first time since the 1990s
5